Masataka Ikeda

3544 POSTER Phase I study of gemcitabine as a fixed dose rate infusion and S-1 combination therapy in gemcitabine-refractory pancreatic cancer patients.

H. Ueno, J. Furuse, M. Ikeda, 2007 .